MICAR INNOVATION (MICAR21)
Micar Innovation is a drug discovery factory. The company has found a niche where it is able to create a large societal impact by improving the quality of life through discovery novel blockbuster drug molecules for a large class of diseases (Pipeline).
MICAR INNOVATION (MICAR21)
Industry:
Artificial Intelligence Biotechnology Genetics Health Care Medical Pharmaceutical
Founded:
2016-02-12
Address:
Sofia, Grad Sofiya, Bulgaria
Country:
Bulgaria
Website Url:
http://www.micar21.com
Total Employee:
1+
Status:
Active
Contact:
+359888531345
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome
Similar Organizations
Cellari
Cellari allows both professionals and non-specialists to benefit from current advances in artificial intelligence.
eCUORE
"Next Generation ECG real-time monitoring and alerting solution using Artificial Intelligence"
Intelligent OMICS
Intelligent OMICS is a translational company that converts big data into biological intelligence.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
Morphochem AG
Morphochem AG is a biotechnology company and provides cure for people affected by clostridium difficile infection.
Okairos
Okairos AG is a biopharmaceutical company focused on the discovery and development of genetic T-cell vaccines, including hepatitis C virus.
Omnia Biosystems
Omnia Biosystems is addressing challenging targets in oncology using artificial intelligence.
Percayai
Reimagining drug discovery by providing innovative augmented intelligence software
XpertFlow
XpertFlow is a technology company revolutionizing the health care industry using its propriety deep tech products.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.micar21.com Semrush global rank: 9 M Semrush visits lastest month: 226
- Host name: vmi1915152.contaboserver.net
- IP address: 45.136.17.50
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "Micar Innovation (Micar21)"
Micar21.com - Drug Discovery Factory - Drug Discovery faster in …
Micar21 is a AI drug discovery factory. The company has found a niche where it is able to create a large societal impact by improving the quality of life through discovery novel blockbuster drug …See details»
Welcome to Micar21 - Modern Innovations
Micar 21 Ltd. provides a wide variety of custom services, which range from in silico drug design to genetic screen analysis and other fields of biotechnology industries.See details»
About-us - micar21.com
Micar Innovation is a AI drug discovery engine. Micar Innovation creates new companies in partnership with pioneering academic researchers and major biopharmaceutical companies, …See details»
Micar21 - Drug Discovery
Micar21 focuses on entire drug discovery process using improved structure based insilico drug design from scratch till Preclinical phase with advanced predictions of activity, selectivity and …See details»
Micar Innovation (Micar21) - Crunchbase Company Profile
Micar21 is a biotechnology company provide Drug Discovery FASTER - using in silico and Artificial Intelligence. Micar Innovation is a drug discovery factory.See details»
Micar Innovation (Micar21.com) - LinkedIn
Micar Innovation focuses on non-clinical Proof-of-Concepts (POCs) in preclinical R&D and Hit-to-Lead (H2L) achievements in areas such as neuroscience, oncology, cardio-vascularity, …See details»
Micar21 Company Profile 2024: Valuation, Funding & Investors
Provider of personalized genetics screen analysis intended to improve quality of life. The company offers in-silico drug design screening for biologically active compounds for …See details»
Micar Innovation (Micar21) - EU-Startups
Micar Innovation focuses on non-clinical Proof-of-Concepts (POCs) in preclinical R&D and Hit-to-Lead (H2L) achievements in areas such as neuroscience, oncology, cardio-vascularity, dermatology, and rare diseases. Micar21 is our …See details»
MICAR21 Ltd - VentureRadar
"Micar21 is a drug discovery factory. The company has found a niche where it is able to create a large societal impact by improving the quality of life through discovery novel blockbuster drug …See details»
Micar Innovation Micar21 - Drug pipelines, Patents, Clinical trials ...
In the current study we performed Free energy of perturbation (FEP) calculations to elucidate it possible impact on a set of neutralizing monoclonal antibodies (mAbs) which have been …See details»
Micar Innovation - Company info. interviews, news
Micar Innovation creates new companies in partnership with pioneering academic researchers and major biopharmaceutical companies, which provide funding and a path to liquidity through pre-negotiated acquisitions. Drug discovery …See details»
Discover our Pipeline - Micar21
Micar21 is actively developing promising first-in-class & best-in-class therapies to treat unmet diseases. The company has a growing product pipeline, with multiple preclinical candidates in …See details»
Micar Innovation Company Profile - Office Locations ... - Craft
Micar Innovation is a company developing therapies to treat unmet and rare genetic diseases. It provides a drug discovery platform Micar21 for small molecule drug candidates with a focus on …See details»
Micar Innovation - Products, Competitors, Financials, Employees ...
Micar Innovation primarily serves the pharmaceutical and biotechnology sectors, providing solutions for human and veterinary medicine. It was founded in 2016 and is based in Sofia, …See details»
Our proof in the Pipeline. See where we are already. - Micar21
Strong and innovative science has always been at the heart of what we are doing in Micar21. Our R & D activities are focused on the application of excellent science to discover and develop …See details»
MIC-2211 - Drug Targets, Indications, Patents - Synapse - Patsnap
MIC-2211, Initially developed by Micar Innovation Micar21, Now, its global highest R&D status is Preclinical, Therapeutic Areas: Nervous System Diseases,Other Diseases, Active Indication: …See details»
Careers - Micar21
We are always on the lookout for talented people, and you are welcome to send your inquiries to [email protected]. We are all about passion with fun, working among friends and …See details»
Company news - Timeline - micar21.com
Micar21 aimed to identify the first in class dual CCR5/CCR7 small molecule antagonists. The company used intensive MD simulations (many1 µs runs) to obtain the CCR7 structure and …See details»
MIC-1045 - Drug Targets, Indications, Patents - Synapse
MIC-1045: a CCR7 inhibitors Drug, Initially developed by Micar Innovation Micar21, Now, its global highest R&D status is Preclinical, Mechanism: CCR7 inhibitors (C-C motif chemokine …See details»
Scientific publications - Micar21
In this study, we present the Free energy of perturbation (FEP) data about the RBD-hACE2 binding of this new variant. We identified two groups of mutations located close to the most …See details»